| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
Purity: ≥98%
| Targets |
Bacterial ribosome (protein synthesis inhibitor)
|
|---|---|
| ln Vitro |
Inhibits protein synthesis in bacteria and is highly effective against Gram-positive and most Gram-negative anaerobic bacteria. The compound's unique structure, composed of five distinct moieties, contributes to its antibiotic activity.
|
| ln Vivo |
No detailed in vivo activity has been reported; the compound is a research tool for studying protein synthesis inhibitors and antibiotic mechanisms. It is a unique nucleoside antibiotic with a complex structure.
|
| Enzyme Assay |
The structure of A201A was elucidated and is composed of 6-dimethylaminopurine, 3-amino-3-deoxyribose, p-hydroxy-alpha-methylcinnamic acid, a novel unsaturated hexofuranose, and 3,4-di-O-methylrhamnose. The compound's structure has been fully characterized.
|
| Cell Assay |
The compound is used as a research reagent to study bacterial protein synthesis, but no specific cell-based assays are detailed in the literature. It serves as a tool for studying nucleoside antibiotic mechanisms.
|
| Animal Protocol |
Not applicable; the compound is primarily used as a research reagent and is not characterized in animal models. It is studied for its antibiotic properties and unique structure.
|
| References |
J Antibiot (Tokyo).2017 Apr;70(4):404-413;J Antibiot (Tokyo).1985 May;38(5):575-86.
|
| Additional Infomation |
A 201A is a 3'-deoxyribonucleoside. (E)-3-[4-[(2R,3S,4R,5Z)-3,4-dihydroxy-5-[2-[(2S,3S,4R,5R,6R)-3-hydroxy-4,5-dimethoxy-6-methyloxacyclopentan-2-yl]oxy-1-methoxyethylidene]oxacyclopentan-2-yl]oxyphenyl]-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purine-9-yl]-4-hydroxy-2-(hydroxymethyl)oxacyclopentan-3-yl]-2-methylprop-2-enamide has been reported in *Marinactinospora thermotolerans*, and relevant data are available. Derived from *Streptomyces capreolus*; structure is given in the first source.
|
| Molecular Formula |
C37H50N6O14
|
|
|---|---|---|
| Molecular Weight |
802.824700000001
|
|
| Exact Mass |
802.339
|
|
| CAS # |
37305-78-5
|
|
| Related CAS # |
|
|
| PubChem CID |
6441582
|
|
| Appearance |
Typically exists as solid at room temperature
|
|
| Density |
1.52g/cm3
|
|
| Index of Refraction |
1.655
|
|
| LogP |
0.038
|
|
| tPSA |
254.42
|
|
| Hydrogen Bond Donor Count |
6
|
|
| Hydrogen Bond Acceptor Count |
18
|
|
| Rotatable Bond Count |
14
|
|
| Heavy Atom Count |
57
|
|
| Complexity |
1400
|
|
| Defined Atom Stereocenter Count |
0
|
|
| SMILES |
COC1C(C)OC(OC/C(=C2/OC(OC3C=CC(/C=C(/C(NC4C(CO)OC(N5C=NC6C(=NC=NC5=6)N(C)C)C4O)=O)\C)=CC=3)C(O)C/2O)/OC)C(O)C1OC
|
|
| InChi Key |
HELPZWNRUYNCJQ-QWJSOBSRSA-N
|
|
| InChi Code |
InChI=1S/C37H50N6O14/c1-17(34(49)41-23-21(13-44)56-35(25(23)45)43-16-40-24-32(42(3)4)38-15-39-33(24)43)12-19-8-10-20(11-9-19)55-37-27(47)26(46)30(57-37)22(50-5)14-53-36-28(48)31(52-7)29(51-6)18(2)54-36/h8-12,15-16,18,21,23,25-29,31,35-37,44-48H,13-14H2,1-7H3,(H,41,49)/b17-12+,30-22-
|
|
| Chemical Name |
(E)-3-[4-[(5Z)-3,4-dihydroxy-5-[2-(3-hydroxy-4,5-dimethoxy-6-methyloxan-2-yl)oxy-1-methoxyethylidene]oxolan-2-yl]oxyphenyl]-N-[5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-2-methylprop-2-enamide
|
|
| Synonyms |
|
|
| HS Tariff Code |
2934.99.9001
|
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
|
|||
|---|---|---|---|---|
| Solubility (In Vivo) |
|
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.2456 mL | 6.2280 mL | 12.4561 mL | |
| 5 mM | 0.2491 mL | 1.2456 mL | 2.4912 mL | |
| 10 mM | 0.1246 mL | 0.6228 mL | 1.2456 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.